New sleep tablet MMH-450 enters first human safety trial
Symptom relief
Completed
This Phase 1 trial evaluates the safety and tolerability of MMH-450, an experimental tablet that dissolves under the tongue, in 18 healthy adults aged 18 to 45 with normal sleep habits. Participants take the drug daily for 7 days while researchers monitor for side effects. The st…
Phase: PHASE1 • Sponsor: Materia Medica Holding • Aim: Symptom relief
Last updated Jul 18, 2026 00:00 UTC